Glenmede Disciplined U.S. Value Equity Portfolio GQLVX

Medalist Rating as of | See Glenmede Investment Hub
  • NAV / 1-Day Return 14.78  /  −0.14 %
  • Total Assets 2.6M
  • Adj. Expense Ratio
    0.850%
  • Expense Ratio 0.850%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Mid-Cap Value
  • Investment Style Mid Value
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 1.35%
  • Turnover 86%

USD | NAV as of Jul 16, 2026 | 1-Day Return as of Jul 16, 2026, 12:11 AM GMT+0

Morningstar’s Analysis GQLVX

Will GQLVX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Glenmede Disciplined US Value Eq Ptf holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GQLVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 23.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

TechnipFMC PLC

2.97 72,033
Energy

Bristol-Myers Squibb Co

2.59 62,833
Healthcare

CME Group Inc Class A

2.48 60,251
Financial Services

Johnson Controls International PLC Registered Shares

2.29 55,654
Industrials

Omnicom Group Inc

2.24 54,524
Communication Services

U.S. Bancorp

2.24 54,506
Financial Services

Exelon Corp

2.22 53,971
Utilities

APA Corp

2.17 52,626
Energy

Hewlett Packard Enterprise Co

2.16 52,549
Technology

Regeneron Pharmaceuticals Inc

2.16 52,540
Healthcare

Sponsor Center